All lobbying filings

Broydrick & Associates

Broydrick & Associates filed a Q2 report for Tonix Pharmaceuticals on July 18, 2026, reporting $20,000 in lobbying income.

Lobbying for Tonix Pharmaceuticals · Pharmaceutical development and manufacturing.

As filed: BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS.

All filings by Broydrick & Associates · Everything Tonix Pharmaceuticals has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 18, 2026.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 18, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.